{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T01:21:04Z","timestamp":1789867264166,"version":"4.0.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2000,7]]},"DOI":"10.1067\/mjd.2000.107809","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T00:22:26Z","timestamp":1027556546000},"page":"S1-S5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"P2","title":["Imiquimod: An immune response modifier"],"prefix":"10.1067","volume":"43","author":[{"given":"Mark V.","family":"Dahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2000.107809_bib1","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0190-9622(99)70261-6","article-title":"Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream","volume":"41","author":"Beutner","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.107809_bib2","article-title":"Safety and efficacy trial evaluating 5% imiquimod cream in the treatment of Bowen\u2019s disease with once daily application","author":"Mackenzie-Wood","year":"1998"},{"key":"10.1067\/mjd.2000.107809_bib3","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1001\/archderm.1986.01660150050014","article-title":"Intralesional recombinant alpha-2 interferon for the treatment of patients with condyloma acuminatum or verruca plantaris","volume":"122","author":"Vance","year":"1986","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2000.107809_bib4","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1056\/NEJM198610233151704","article-title":"Interferon therapy for condylomata acuminata","volume":"315","author":"Eron","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2000.107809_bib5","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1517\/13543784.7.3.437","article-title":"Imiquimod 5% cream (Aldara)","volume":"7","author":"Slade","year":"1998","journal-title":"Exp Opin Invest Drugs"},{"key":"10.1067\/mjd.2000.107809_bib6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1128\/AAC.42.4.789","article-title":"Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts","volume":"42","author":"Beutner","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1067\/mjd.2000.107809_bib7","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1001\/archderm.135.10.1167","article-title":"Topical imiquimod therapy for chronic giant molluscum contagiosum in a patient with advanced human immunodeficiency virus 1 disease","volume":"135","author":"Buckley","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2000.107809_bib8","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1046\/j.1523-1747.1998.00174.x","article-title":"Cytokine induction in hairless mouse and rat skin after topical application of the immune response modifiers imiquimod and S-28463","volume":"110","author":"Imbertson","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2000.107809_bib9","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1086\/517472","article-title":"A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod","volume":"178","author":"Tyring","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1067\/mjd.2000.107809_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1006\/clim.1999.4804","article-title":"The imid-azoquinolines, imiquimod and R-848, induce functional but not phenotypic maturation of human epidermal Langerhans\u2019 cells","volume":"94","author":"Burns","year":"2000","journal-title":"Clin Immunol"},{"key":"10.1067\/mjd.2000.107809_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archderm.134.1.25","article-title":"Self-administered topical 5% imiquimod cream for external anogenital warts","volume":"134","author":"Edwards","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2000.107809_bib12","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0140-6736(77)92896-3","article-title":"Induction of hair growth in alopecia areata with DNCB","volume":"2","author":"Happle","year":"1977","journal-title":"Lancet"},{"key":"10.1067\/mjd.2000.107809_bib13","first-page":"3528","article-title":"Inhibition of murine tumor growth by an interferon-inducing imidazoquinolinamine","volume":"52","author":"Sidky","year":"1992","journal-title":"Cancer Res"},{"key":"10.1067\/mjd.2000.107809_bib14","first-page":"5176","article-title":"Phase I trial of an oral immunomodulator and interferon inducer in cancer patients","volume":"53","author":"Witt","year":"1993","journal-title":"Cancer Res"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962200960754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962200960754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:22:28Z","timestamp":1759267348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962200960754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,7]]}},"alternative-id":["S0190962200960754"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2000.107809","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2000,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imiquimod: An immune response modifier","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1067\/mjd.2000.107809","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}